Join to View Full Profile
Piedmont Cancer Institute4877 Bill Gardner PkwyLocust Grove, GA 30248
Phone+1 678-399-7190
Dr. Nazha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Hematologist and Medical Oncologist with a specialized focus in Genitourinary Oncology
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2020
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2017
Columbia UniversityMPH, Health Policy and Management, 2014
American University of Beirut Faculty of MedicineClass of 2013, MD- McGill UniversityBS, Biology, Great Distinction, 2008
Certifications & Licensure
GA State Medical License 2020 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma Start of enrollment: 2021 May 20
Roles: Principal Investigator, Contact
- Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer Start of enrollment: 2025 Jan 15
Roles: Contact, Principal Investigator
- Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology Start of enrollment: 2023 Sep 26
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617.Margo B Gerke, Angelo Marra, Yuan Liu, Akshay Bedmutha, Jacqueline T Brown
Cancer. 2026-04-15 - Phase II Trial of Opaganib Addition in Metastatic Castration-Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide.Jacqueline T Brown, Bassel Nazha, Anna C Ferreira, Kent Armeson, Elizabeth G Hill
Cancer Medicine. 2026-04-01 - Clinical outcomes of lutetium-177-PSMA-617 in a racially diverse cohort of patients with metastatic castration-resistant prostate cancer.Margo Brooke Gerke, Akshay Bedmutha, Angelo Marra, Yuan Liu, Jacqueline T Brown
The Oncologist. 2026-02-05
Press Mentions
The Case for Immunotherapy Trials That Reflect the Real World of Metastatic MelanomaSeptember 13th, 2019
With Millions at Stake, Oncologists Question Ethics of New Billing PracticeMay 14th, 2024
Other Languages
- French, Arabic
External Links
- Winship Cancer Institute profilehttps://winshipcancer.emory.edu/bios/faculty/nazha-bassel.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
